Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Cimmino

Showing results (81-90 of 123) with videos related to

Pageof 13
Sort By:
European Heart Journal|March 23, 2010
Recombinant apolipoprotein A-I Milano rapidly reverses aortic valve stenosis and decreases leaflet inflammation in an experimental rabbit modelWalter S Speidl, Giovanni Cimmino, Borja Ibanez, et al.
International Journal of Cardiology|November 17, 2009
The cardioprotection granted by metoprolol is restricted to its administration prior to coronary reperfusionBorja Ibanez, Giovanni Cimmino, Susanna Prat-González, et al.
Journal of Interventional Cardiology|December 8, 2016
Prognostic Factors in Patients With Stemi Undergoing Primary PCI in the Clopidogrel Era: Role of Dual Antiplatelet Therapy at Admission and the Smoking Paradox on Long-Term OutcomeGiovanni Ciccarelli, Emanuele Barbato, Marco Golino, et al.
Journal of Cardiovascular Pharmacology|December 18, 2010
Adeno-associated virus serotype 8 ApoA-I gene transfer reduces progression of atherosclerosis in ApoE-KO mice: comparison of intramuscular and intravenous administrationGiovanni Cimmino, Chiara Giannarelli, Wei Chen, et al.
Atherosclerosis|October 28, 2011
Recombinant HDL(Milano) exerts greater anti-inflammatory and plaque stabilizing properties than HDL(wild-type)Borja Ibanez, Chiara Giannarelli, Giovanni Cimmino, et al.
Genes|December 30, 2025
<i>APOE</i> Genotype and Endothelial Biomarkers: Towards Personalized Cardiovascular ScreeningGisella Titolo, Mariarosaria Morello, Silvia Caiazza, et al.
International Journal of Environmental Research and Public Health|December 30, 2020
Cardiovascular Comorbidities and Pharmacological Treatments of COVID-19 Patients Not Requiring HospitalizationVincenzo Russo, Gaetano Piccinocchi, Vincenzo Mandaliti, et al.
Circulation|May 23, 2007
Early metoprolol administration before coronary reperfusion results in increased myocardial salvage: analysis of ischemic myocardium at risk using cardiac magnetic resonanceBorja Ibanez, Susanna Prat-González, Walter S Speidl, et al.
Vascular Pharmacology|October 6, 2018
Colchicine reduces platelet aggregation by modulating cytoskeleton rearrangement via inhibition of cofilin and LIM domain kinase 1Giovanni Cimmino, Roberta Tarallo, Stefano Conte, et al.
Thrombosis and Haemostasis|October 25, 2012
Acute ApoA-I Milano administration induces plaque regression and stabilisation in the long termChiara Giannarelli, Giovanni Cimmino, Borja Ibanez, et al.
Pageof 13

Showing results (81-90 of 123) with videos related to

Sort By:
Pageof 13
European Heart Journal|March 23, 2010
Recombinant apolipoprotein A-I Milano rapidly reverses aortic valve stenosis and decreases leaflet inflammation in an experimental rabbit modelWalter S Speidl, Giovanni Cimmino, Borja Ibanez, et al.
International Journal of Cardiology|November 17, 2009
The cardioprotection granted by metoprolol is restricted to its administration prior to coronary reperfusionBorja Ibanez, Giovanni Cimmino, Susanna Prat-González, et al.
Journal of Interventional Cardiology|December 8, 2016
Prognostic Factors in Patients With Stemi Undergoing Primary PCI in the Clopidogrel Era: Role of Dual Antiplatelet Therapy at Admission and the Smoking Paradox on Long-Term OutcomeGiovanni Ciccarelli, Emanuele Barbato, Marco Golino, et al.
Journal of Cardiovascular Pharmacology|December 18, 2010
Adeno-associated virus serotype 8 ApoA-I gene transfer reduces progression of atherosclerosis in ApoE-KO mice: comparison of intramuscular and intravenous administrationGiovanni Cimmino, Chiara Giannarelli, Wei Chen, et al.
Atherosclerosis|October 28, 2011
Recombinant HDL(Milano) exerts greater anti-inflammatory and plaque stabilizing properties than HDL(wild-type)Borja Ibanez, Chiara Giannarelli, Giovanni Cimmino, et al.
Genes|December 30, 2025
<i>APOE</i> Genotype and Endothelial Biomarkers: Towards Personalized Cardiovascular ScreeningGisella Titolo, Mariarosaria Morello, Silvia Caiazza, et al.
International Journal of Environmental Research and Public Health|December 30, 2020
Cardiovascular Comorbidities and Pharmacological Treatments of COVID-19 Patients Not Requiring HospitalizationVincenzo Russo, Gaetano Piccinocchi, Vincenzo Mandaliti, et al.
Circulation|May 23, 2007
Early metoprolol administration before coronary reperfusion results in increased myocardial salvage: analysis of ischemic myocardium at risk using cardiac magnetic resonanceBorja Ibanez, Susanna Prat-González, Walter S Speidl, et al.
Vascular Pharmacology|October 6, 2018
Colchicine reduces platelet aggregation by modulating cytoskeleton rearrangement via inhibition of cofilin and LIM domain kinase 1Giovanni Cimmino, Roberta Tarallo, Stefano Conte, et al.
Thrombosis and Haemostasis|October 25, 2012
Acute ApoA-I Milano administration induces plaque regression and stabilisation in the long termChiara Giannarelli, Giovanni Cimmino, Borja Ibanez, et al.
Pageof 13